InsiderClue
Insiders · Profile

Polaris Venture Management Co. V, L.L.C.

10% owner at Phreesia · 10% owner at Cardlytics · 10% owner at X4 Pharmaceuticals · and 4 more. Filing since 4 Oct 2013. CIK 0001439589

PHR Phreesia, Inc. 10% owner · 8 trades CDLX Cardlytics, Inc. 10% owner · 10 trades XFOR X4 Pharmaceuticals, Inc 10% owner · 2 trades RNAC Cartesian Therapeutics, Inc. 10% owner · 1 trade OCUL OCULAR THERAPEUTIX, INC 10% owner · 1 trade DARE Dare Bioscience, Inc. 10% owner · 1 trade FATE FATE THERAPEUTICS INC 10% owner · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
PHR Phreesia, Inc.
17 Dec 2019
10% owner
Sold, plan not stated
344,599
$8.44M
10.0%
PHR Phreesia, Inc.
17 Dec 2019
10% owner
Sold, plan not stated
6,716
$164.40K
10.0%
PHR Phreesia, Inc.
17 Dec 2019
10% owner
Sold, plan not stated
3,446
$84.35K
10.0%
PHR Phreesia, Inc.
17 Dec 2019
10% owner
Sold, plan not stated
2,360
$57.77K
10.0%
PHR Phreesia, Inc.
22 Jul 2019
10% owner
Sold, plan not stated
382,887
$6.89M
10.0%
PHR Phreesia, Inc.
22 Jul 2019
10% owner
Sold, plan not stated
7,462
$134.32K
10.0%
PHR Phreesia, Inc.
22 Jul 2019
10% owner
Sold, plan not stated
3,828
$68.90K
10.0%
PHR Phreesia, Inc.
22 Jul 2019
10% owner
Sold, plan not stated
2,622
$47.20K
10.0%
CDLX Cardlytics, Inc.
17 Jul 2019
10% owner
Sold, plan not stated
27,781
$762.51K
65.6%
CDLX Cardlytics, Inc.
16 Jul 2019
10% owner
Sold, plan not stated
20,962
$584.19K
58.7%
CDLX Cardlytics, Inc.
15 Jul 2019
10% owner
Sold, plan not stated
19,984
$554.07K
57.3%
CDLX Cardlytics, Inc.
7 Jun 2019
10% owner
Sold, plan not stated
100,000
$2.56M
86.9%
CDLX Cardlytics, Inc.
6 Jun 2019
10% owner
Sold, plan not stated
305
$7.63K
1.9%
CDLX Cardlytics, Inc.
5 Jun 2019
10% owner
Sold, plan not stated
38,601
$959.51K
71.1%
CDLX Cardlytics, Inc.
4 Jun 2019
10% owner
Sold, plan not stated
36,378
$846.94K
69.5%
CDLX Cardlytics, Inc.
28 May 2019
10% owner
Sold, plan not stated
100,000
$2.30M
86.1%
CDLX Cardlytics, Inc.
13 Sep 2018
Director
Sold, plan not stated
50,000
$1.28M
74.8%
CDLX Cardlytics, Inc.
12 Sep 2018
Director
Sold, plan not stated
100,000
$2.48M
85.3%
XFOR X4 Pharmaceuticals, Inc
20 Nov 2017
10% owner
Bought
482,467
$4.82M
36.5%
XFOR X4 Pharmaceuticals, Inc
20 Nov 2017
10% owner
Bought
17,533
$175.33K
99.5%
RNAC Cartesian Therapeutics, Inc.
27 Jun 2016
10% owner
Bought
150,000
$2.10M
8.9%
OCUL OCULAR THERAPEUTIX, INC
2 Feb 2015
10% owner
Sold, plan not stated
500,000
$14.75M
97.4%
DARE Dare Bioscience, Inc.
15 Apr 2014
10% owner
Bought
1,470,582
$10.29M
82.1%
FATE FATE THERAPEUTICS INC
4 Oct 2013
10% owner
Bought
804,112
$4.82M
49.0%
FATE FATE THERAPEUTICS INC
4 Oct 2013
10% owner
Bought
15,672
$94.03K
0.6%
FATE FATE THERAPEUTICS INC
4 Oct 2013
10% owner
Bought
8,041
$48.25K
0.3%
FATE FATE THERAPEUTICS INC
4 Oct 2013
10% owner
Bought
5,508
$33.05K
0.2%
27 decisions on file.